MyMD Pharmaceuticals, Inc.
NASDAQ:MYMD
Overview | Financials
Company Name | MyMD Pharmaceuticals, Inc. |
Symbol | MYMD |
Currency | USD |
Price | 1.81 |
Market Cap | 4,290,460 |
Dividend Yield | 0% |
52-week-range | 1.75 - 63.9 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Christopher C. Chapman Jr., M.D. |
Website | https://www.mymd.com |
An error occurred while fetching data.
About MyMD Pharmaceuticals, Inc.
MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD